Contemporary Management of HIV: ART Management in Heavily Treatment Experienced Patients

ART Management in Heavily Treatment Experienced Patients Workshop (2020)

Wednesday, November 4, 2020
Webinar -- 6:00 PM CT
https://www.clinicaloptions.com/2020ContemporaryMgtWebinarHeavilyJoin10

Agenda

The timing and agenda for each webinar is as follows:

  • Introduction and program overview (5 mins)
  • Update and discussion on assessment of virologic failure and current ART options for patients with multiclass resistance (20-25 mins)
  • Case-based discussion on selecting next line therapy for patients with extensive treatment histories (45-50 mins)
  • Question and answer session (15 mins)

Faculty

Faculty
Roger Bedimo, MD

Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Faculty
Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

This educational activity is not certified for CME/CE credit.

Goal Statement
The goal of this activity is to improve learners’ competence in providing optimal care for HIV-infected patients through the appropriate use of contemporary ARV regimens.

Target Audience
This program is intended for physicians, registered nurses, physician assistants, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Perform appropriate assessments of patients with virologic failure in the setting of extensive treatment history and complex resistance, assessing factors contributing to failure and clinical and laboratory parameters relevant to the selection of a new regimen
  • Appropriately counsel patients on potential management strategies for virologic failure in the setting of an extensive treatment history and multiclass drug resistance
  • Describe the mechanisms of action, efficacy, and safety of agents with activity against multidrug-resistant HIV in treatment-experienced patients

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Pharmacist Continuing Education

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. UAN: JA4008176-0000-20-109-L02-P

Activity type: Application

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.